151 related articles for article (PubMed ID: 21296659)
1. Mouse embryonic stem cell adherent cell differentiation and cytotoxicity (ACDC) assay.
Barrier M; Jeffay S; Nichols HP; Chandler KJ; Hoopes MR; Slentz-Kesler K; Hunter ES
Reprod Toxicol; 2011 May; 31(4):383-91. PubMed ID: 21296659
[TBL] [Abstract][Full Text] [Related]
2. Mouse embryonic stem cell adherent cell differentiation and cytotoxicity assay.
Barrier M; Chandler K; Jeffay S; Hoopes M; Knudsen T; Hunter S
Methods Mol Biol; 2012; 889():181-95. PubMed ID: 22669665
[TBL] [Abstract][Full Text] [Related]
3. Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
de Jong E; Doedée AM; Reis-Fernandes MA; Nau H; Piersma AH
Reprod Toxicol; 2011 May; 31(4):375-82. PubMed ID: 21115111
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide induced early gene expression perturbations indicative of human embryopathy in mouse embryonic stem cells.
Gao X; Sprando RL; Yourick JJ
Toxicol Appl Pharmacol; 2015 Aug; 287(1):43-51. PubMed ID: 26006729
[TBL] [Abstract][Full Text] [Related]
5. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.
Peters AK; Steemans M; Hansen E; Mesens N; Verheyen GR; Vanparys P
Toxicol Sci; 2008 Oct; 105(2):342-50. PubMed ID: 18593728
[TBL] [Abstract][Full Text] [Related]
7. The embryonic stem cell test.
Schulpen SH; Piersma AH
Methods Mol Biol; 2013; 947():375-82. PubMed ID: 23138917
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol promotes differentiation of mouse embryonic stem cells to cardiomyocytes.
Ding H; Xu X; Qin X; Yang C; Feng Q
Cardiovasc Ther; 2016 Aug; 34(4):283-9. PubMed ID: 27225714
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of field potential as a marker of embryonic stem cell-derived cardiomyocytes, and endpoint analysis of embryonic stem cell test.
Koseki N; Deguchi J; Yamada T; Funabashi H; Seki T
J Toxicol Sci; 2010 Dec; 35(6):899-909. PubMed ID: 21139340
[TBL] [Abstract][Full Text] [Related]
10. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures.
van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
Toxicol Sci; 2011 Jan; 119(1):126-34. PubMed ID: 20935163
[TBL] [Abstract][Full Text] [Related]
12. Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity.
Osman AM; van Dartel DA; Zwart E; Blokland M; Pennings JL; Piersma AH
Reprod Toxicol; 2010 Sep; 30(2):322-32. PubMed ID: 20553848
[TBL] [Abstract][Full Text] [Related]
13. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
Stummann TC; Hareng L; Bremer S
Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
[TBL] [Abstract][Full Text] [Related]
14. Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity.
Louisse J; Gönen S; Rietjens IM; Verwei M
Toxicol Lett; 2011 May; 203(1):1-8. PubMed ID: 21362465
[TBL] [Abstract][Full Text] [Related]
15. Specific effect of 5-fluorouracil on alpha-fetoprotein gene expression during the in vitro mouse embryonic stem cell differentiation.
Pamies D; Vicente-Salar N; Sogorb MA; Roche E; Reig JA
Int J Toxicol; 2010; 29(3):297-304. PubMed ID: 20448262
[TBL] [Abstract][Full Text] [Related]
16. Mouse embryonic stem cells irradiated with γ-rays differentiate into cardiomyocytes but with altered contractile properties.
Rebuzzini P; Fassina L; Mulas F; Bellazzi R; Redi CA; Di Liberto R; Magenes G; Adjaye J; Zuccotti M; Garagna S
Mutat Res; 2013 Aug; 756(1-2):37-45. PubMed ID: 23792212
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatotoxicity of chemicals using hepatic progenitor and hepatocyte-like cells derived from mouse embryonic stem cells: effect of chemicals on ESC-derived hepatocyte differentiation.
Kang SJ; Jeong SH; Kim EJ; Cho JH; Park YI; Park SW; Shin HS; Son SW; Kang HG
Cell Biol Toxicol; 2013 Feb; 29(1):1-11. PubMed ID: 23108452
[TBL] [Abstract][Full Text] [Related]
18. First steps in establishing a developmental toxicity test method based on human embryonic stem cells.
Adler S; Pellizzer C; Hareng L; Hartung T; Bremer S
Toxicol In Vitro; 2008 Feb; 22(1):200-11. PubMed ID: 17961973
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling reveals the heterogeneous transcriptional activity of Oct3/4 and its possible interaction with Gli2 in mouse embryonic stem cells.
Li Y; Drnevich J; Akraiko T; Band M; Li D; Wang F; Matoba R; Tanaka TS
Genomics; 2013; 102(5-6):456-67. PubMed ID: 24121003
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells.
van Dartel DA; Pennings JL; van Schooten FJ; Piersma AH
Toxicol Appl Pharmacol; 2010 Mar; 243(3):420-8. PubMed ID: 20036270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
